Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007307 |
---|---|
Receipt number | R000008618 |
Scientific Title | The randomized phaseII study about the skin hazard mitigation in the Erlotinib + oral steroid agent combined therapy and Erlotinib to non-small cell lung cancer patients |
Date of disclosure of the study information | 2012/02/16 |
Last modified on | 2016/06/21 23:03:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/02/16 15:31:47 | ||
2 | Update | 2014/03/05 00:02:25 | Date of closure to data entry Date trial data considered complete |
|
3 | Update | 2016/06/21 23:01:18 | TEL Name of primary person or sponsor Organization |
|
4 | Update | 2016/06/21 23:02:03 | Date analysis concluded |
|
5 | Update | 2016/06/21 23:03:30 | Recruitment status |